Clinical research

MARS Imaging System

Since 2019, MARS have been conducting human clinical trials for orthopaedic and cardiovascular applications through collaboration with the University of Canterbury, University of Otago and Canterbury DHB. We are excited to announce that we have now expanded our clinical trials into the local acute care clinic through a partnership with New Zealand’s largest Radiology provider. The orthopaedic trials to date have shown that we are able to provide high-resolution imaging of patients in the acute, follow-up, pre-surgical and post-surgical stages.  


We are looking forward to our European partners conducting clinical trials in the near future to extend pre-clinical research for clinical rheumatology applications

Our clinical focus


Advanced imaging for suspected wrist fractures where and when you need it

It is well known that scaphoid fractures are a common and challenging orthopaedic issue that has the potential to become chronic and debilitating.


The clinical management pathway involves immobilisation and repeat plain radiographs, MRI or cone-beam CT and multiple visits to the imaging department. This pathway is costly in many ways, both for the patient and for the funding provider.


The MARS Imaging System is compact and shielded for safe, point-of-care scanning. Perform low-dose, high-resolution imaging, allowing scaphoid and other carpal bone fractures to be confirmed or ruled out at first presentation.


Click here to learn more.

Looking at knee implants in a whole new way

Osteoarthritis is the single most common cause of disability in elderly patients. The most common site is the knee. When conservative efforts fail, effective treatment comes in the form of a total knee arthroplasty (TKA) or knee replacement. 


Despite it's frequent use, TKA is associated with suboptimal results in 20% of patients. These patients suffer from plain and functional limitations. Establishing why the implant is failing is crucial for appropriate management.


The MARS Imaging System enables you to image damage that is otherwise not detectable on any other non-invasive, ore-operative imaging modality.


To learn more about this topic, click here.


'Risk factors' redundant with non-invasive characterisation of atherosclerotic plaque 

Plaque formation in our blood vessels is a normal part of aging. However, when a plaque becomes so large that it disrupts normal blood flow, atherosclerotic disease occurs, which has the potential to lead to ischemic heart disease and stroke – the two leading causes of death worldwide.


The different components or materials making up a plaque indicate its vulnerablity to rupture (and cause stroke or death). Currently, the decision to move to surgical management is determined by risk factors, such as family history and smoking.


Using the spectral nature of MARS Imaging, you can characterise plaque composition to assist in the diagnostic and interventional decision making process.


Click here to learn more.

A bright future: Lighting up plaques using gold labelled white blood cells

Information about this. 

Click here to sign up to out newsletter